Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 26
2003 36
2004 23
2005 29
2006 24
2007 26
2008 16
2009 21
2010 11
2011 7
2012 12
2013 8
2014 10
2015 8
2016 8
2017 6
2018 5
2019 3
2020 3
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

263 results
Results by year
Filters applied: . Clear all
Page 1
The proteasome and proteasome inhibitors in multiple myeloma.
Gandolfi S, Laubach JP, Hideshima T, Chauhan D, Anderson KC, Richardson PG. Gandolfi S, et al. Among authors: hideshima t. Cancer Metastasis Rev. 2017 Dec;36(4):561-584. doi: 10.1007/s10555-017-9707-8. Cancer Metastasis Rev. 2017. PMID: 29196868 Review.
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.
Richardson PG, Weller E, Lonial S, Jakubowiak AJ, Jagannath S, Raje NS, Avigan DE, Xie W, Ghobrial IM, Schlossman RL, Mazumder A, Munshi NC, Vesole DH, Joyce R, Kaufman JL, Doss D, Warren DL, Lunde LE, Kaster S, Delaney C, Hideshima T, Mitsiades CS, Knight R, Esseltine DL, Anderson KC. Richardson PG, et al. Among authors: hideshima t. Blood. 2010 Aug 5;116(5):679-86. doi: 10.1182/blood-2010-02-268862. Epub 2010 Apr 12. Blood. 2010. PMID: 20385792 Free PMC article. Clinical Trial.
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Ho M, Chen T, Liu J, Dowling P, Hideshima T, Zhang L, Morelli E, Camci-Unal G, Wu X, Tai YT, Wen K, Samur M, Schlossman RL, Mazitschek R, Kavanagh EL, Lindsay S, Harada T, McCann A, Anderson KC, O'Gorman P, Bianchi G. Ho M, et al. Among authors: hideshima t. Leukemia. 2020 Jan;34(1):196-209. doi: 10.1038/s41375-019-0493-x. Epub 2019 May 29. Leukemia. 2020. PMID: 31142847 Free PMC article.
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP, Weinstock J, Kingsbury WD, Hideshima T, Shah PK, Minvielle S, Altun M, Kessler BM, Orlowski R, Richardson P, Munshi N, Anderson KC. Chauhan D, et al. Among authors: hideshima t. Cancer Cell. 2012 Sep 11;22(3):345-58. doi: 10.1016/j.ccr.2012.08.007. Cancer Cell. 2012. PMID: 22975377 Free PMC article.
PRMT5 inhibitors on the (myeloma) road.
Gulla A, Hideshima T, Anderson KC. Gulla A, et al. Among authors: hideshima t. Oncotarget. 2018 Nov 30;9(94):36646-36647. doi: 10.18632/oncotarget.26392. eCollection 2018 Nov 30. Oncotarget. 2018. PMID: 30613345 Free PMC article. No abstract available.
263 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page